PharmaSGP Holding SE reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was EUR 46.17 million compared to EUR 48.56 million a year ago. Net income was EUR 8.3 million compared to EUR 10.53 million a year ago. Basic earnings per share from continuing operations was EUR 0.69 compared to EUR 0.88 a year ago.